TheodoreRoszak. Where the Wasteland Ends.New York: Doubleday, 1973: 142
2.
VereD.. Controlled clinical trials: the current ethical debate [Editorial].J R Soc Med1981; 74: 85–8
3.
ValleeA.. Un biologiste Canadien: Michel Sarrazin 1659–1735.Quebec: LS-A Proulx, 1927
4.
LewisD., ReinhoffW.F.. A study of the results of operations for the cure of carcinoma of the breast performed at the Johns Hopkins Hospital from 1889–1931.Ann Sura1932; 95: 336–49
5.
BrinkleyD., HaybittleJ.L.. The curability of breast cancer.Lancet1973; ii: 95–8
6.
BaumM.. The curability of breast cancer. In: StollB.A., ed. Breast Cancer Management—Early and Late.London: Heinemann, 1977: 3–14
7.
PopperK.R.. The Logic of Scientific Discovery.London: Hutchinson, 1968
8.
EBCTCG. Effects of radiotherapy and surgery in early breast cancer, an overview of the randomized trials.New Engl J Med1975; 333: 1444–55
9.
EBCTCG.Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy.Lancet1992; 339: 1–15, 71–85.
10.
BaumM., EbbsS., BrooksM., CollettaA.. Biological fallout from trials of adjuvant tamoxifen in early breast cancer. In: SalmonS.E., ed. Adjuvant Therapy of Cancer, vol VI. Philadelphia: WB Saunders, 1990: 269–74
11.
SchipperH., GohC.R., WangT.L.. Shifting the cancer paradigm: must we kill to cure?J Clin Oncol1995; 13: 801–7
12.
BeralV., HermonG., ReevesG., PetoR.. Sudden fall in breast cancer death rates in England and Wales.Lancet1995; 345: 1642–3